GH Research (GHRS) Net Cash Flow (2020 - 2025)
GH Research (GHRS) recorded quarterly Net Cash Flow of -$6.8 million in Q4 2025, up 7.7% quarter-over-quarter from -$7.3 million in Q3 2025, and down 179.17% on a YoY basis from $8.5 million in Q4 2024.
GH Research (GHRS) Net Cash Flow (2020 - 2025) Analysis & Trends
GH Research's Net Cash Flow history runs 6 years deep, the most recent figure standing at -$6.8 million for Q4 2025.
- In Q4 2025, Net Cash Flow fell 179.17% year-over-year to -$6.8 million; the TTM figure through Dec 2025 stood at $130.8 million (up 708.07% YoY), while the FY2025 annual figure was $130.8 million, up 708.07% from the prior year.
- Net Cash Flow was -$6.8 million for Q4 2025 at GH Research, up from -$7.3 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $195.1 million in Q4 2022 to a low of -$61.4 million in Q1 2023.
- Historically, Net Cash Flow has averaged $10.8 million across 5 years, with a median of -$4.6 million in 2021.
- The sharpest annual moves came in 2021 and 2025: Net Cash Flow tumbled 15305.19% in 2021, then soared 7579.6% in 2025.
- A 5-year view of Net Cash Flow shows it stood at -$4.0 million in 2021, then jumped by 5030.81% to $195.1 million in 2022, then sank by 105.09% to -$9.9 million in 2023, then jumped by 185.95% to $8.5 million in 2024, then plunged by 179.17% to -$6.8 million in 2025.
- The last three Net Cash Flow figures came in at -$6.8 million (Q4 2025), -$7.3 million (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 664,983.53 |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | -6.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.76 Mn |
| Dec 31, 2025 | -6.76 Mn |
| Sep 30, 2025 | -7.33 Mn |
| Sep 30, 2025 | -7.33 Mn |
| Jun 30, 2025 | 3.05 Mn |
| Jun 30, 2025 | 3.05 Mn |
| Mar 31, 2025 | 141.89 Mn |
| Mar 31, 2025 | 141.89 Mn |
| Dec 31, 2024 | 8.54 Mn |
| Dec 31, 2024 | 8.54 Mn |
| Sep 30, 2024 | 1.53 Mn |
| Sep 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 8.02 Mn |
| Jun 30, 2024 | 8.02 Mn |
| Mar 31, 2024 | -1.90 Mn |
| Mar 31, 2024 | -1.90 Mn |
| Dec 31, 2023 | -9.94 Mn |
| Dec 31, 2023 | -9.94 Mn |
| Sep 30, 2023 | -11.05 Mn |
| Sep 30, 2023 | -11.05 Mn |